المؤلفون: Tuttle, R. M., Haddad, R. I., Ball, D. W., Byrd, D., Dickson, P., Duh, Q. -Y, Ehya, H., Haymart, M., Hoh, C., Hunt, J. P., Iagaru, A., Kandeel, F., Kopp, P., Lamonica, D. M., Lydiatt, W. M., Mccaffrey, J., Moley, J. F., Parks, L., Raeburn, C. D., Ridge, J. A., Ringel, M. D., Scheri, R. P., Shah, J. P., Steven Sherman, Sturgeon, C., Waguespack, S. G., Wang, T. N., Wirth, L. J., Hoffmann, K. G., Hughes, M.

المصدر: JNCCN Journal of the National Comprehensive Cancer Network, vol 12, iss 12
Scopus-Elsevier
Tuttle, RM; Haddad, RI; Ball, DW; Byrd, D; Dickson, P; Duh, QY; et al.(2014). Thyroid carcinoma, version 2.2014: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 12(12), 1671-1680. doi: 10.6004/jnccn.2014.0169. UCSF: Retrieved from: http://www.escholarship.org/uc/item/98h712mx

مصطلحات موضوعية: endocrine system, Rare Diseases, endocrine system diseases, 6.1 Pharmaceuticals, Oncology & Carcinogenesis, 6.2 Cellular and gene therapies, Cancer

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8844c98f5edf7130d9973d74a6433376
https://escholarship.org/uc/item/98h712mx

المؤلفون: Hoffmann, K. G.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::9eaf17fa4d89338583d29df5550a804b